Related Experiment Video
Updated: Jul 17, 2026

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
Nucleic acids with a six-membered carbohydrate mimic and RNA interference
Piet Herdewijn1, Rudolph Juliano
1The Laboratory of Medicinal Chemistry, Rega Institute for Medical Research, Minderbroedersstraat 10, B-3000 Leuven, Belgium. piet.Herdewijn@rega.kuleuven.ac.be
Cyclohexenyl nucleic acids and altritol nucleic acids enhance RNA interference. These modifications improved the potency and duration of gene silencing effects in an siRNA experiment.
Area of Science:
- Biochemistry
- Molecular Biology
- Oligonucleotide Chemistry
Background:
- RNA interference (RNAi) is a powerful gene-silencing mechanism.
- Short interfering RNA (siRNA) therapeutics offer potential for treating various diseases.
- Chemical modifications of siRNA are crucial for improving stability, delivery, and efficacy.
Purpose of the Study:
- To evaluate cyclohexenyl nucleic acids (CHNA) and altritol nucleic acids (ANA) as chemical modifications for siRNA.
- To assess the impact of these modifications on the potency and duration of gene silencing.
- To investigate their potential as RNA mimics in therapeutic applications.
Main Methods:
- Design and synthesis of siRNA duplexes incorporating CHNA and ANA modifications.
- In vitro evaluation of siRNA stability and nuclease resistance.
- In vivo assessment of gene silencing efficacy targeting P-glycoprotein expression in an siRNA experiment.
- Pharmacokinetic studies to determine the duration of action.
Main Results:
- Both CHNA and ANA modifications were well accepted as RNA mimics.
- The modified oligonucleotides demonstrated enhanced acceptance as RNA mimics.
- A significant increase in the potency and duration of the gene-silencing effect was observed with both modifications.
Conclusions:
- CHNA and ANA represent promising modifications for enhancing siRNA efficacy.
- These modifications improve the pharmacokinetic profile and gene-silencing activity of siRNAs.
- Further development of CHNA and ANA could lead to more effective RNAi-based therapeutics.
More Related Videos
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
Nucleic Acid Structure
DNA Structure
DNA has a double-helix structure. The...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Types of RNA
RNA Performs Diverse...

